London, United Kingdom

Steven Godfrey Lane

This inventor holds 5 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Medimmune Limited. Active years: 2012-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven Godfrey Lane. Retrieved from https://idiyas.com/inventor/steven-godfrey-lane

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 80.0


 

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • London, GB (2012)
  • Cambridge, GB (2012 - 2016)

Company Filing History:


Years Active: 2012-2016

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Steven Godfrey Lane: Innovator in Antibody Therapeutics

Introduction

Steven Godfrey Lane is a prominent inventor based in London, GB. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of five patents to his name, Lane's work focuses on innovative solutions for medical challenges.

Latest Patents

Among his latest patents is the invention of Anti-IL-18 antibodies and their uses. This invention provides human, humanized, and/or chimeric antibodies, along with fragments, derivatives, and compositions that specifically bind to interleukin-18. The invention also includes the application of these antibodies for diagnosing and treating diseases associated with increased IL-18 activity, particularly in the form of a pharmaceutical composition. Another notable patent involves compounds that serve as binding members, such as human antibody molecules that bind interleukin-6 (IL-6) and neutralize its biological effects. This patent emphasizes the use of these binding members in medical treatments for inflammatory diseases and tumors associated with IL-6.

Career Highlights

Steven Godfrey Lane has had a distinguished career, working with leading companies in the biotechnology sector. He has been associated with MedImmune Limited and AstraZeneca AB, where he has contributed to groundbreaking research and development in antibody therapeutics.

Collaborations

Lane has collaborated with notable professionals in his field, including Philip Mallinder and Simon Charles Cruwys. These collaborations have further enhanced his research and innovation capabilities.

Conclusion

Steven Godfrey Lane's contributions to the field of antibody therapeutics exemplify his commitment to advancing medical science. His innovative patents and collaborations highlight his role as a key figure in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…